01 4Gilead Sciences Canada Inc.
01 12682230
02 12794669
03 12815082
04 12921160
01 3SOFOSBUVIR / VELPATASVIR
02 1SOFOSBUVIR | VELPATASVIR
01 4TABLET
01 12028-03-26
02 12031-03-31
03 12032-11-16
04 12034-01-30
Patent Expiration Date : 2028-03-26
Date Granted : 2014-04-22
Brand Name : EPCLUSA
Patent Number : 2682230
Filing Date : 2008-03-26
Strength per Unit : 400 mg / 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-03-26
Date Granted : 2014-04-22
Patent Expiration Date : 2032-11-16
Date Granted : 2015-07-07
Brand Name : EPCLUSA
Patent Number : 2815082
Filing Date : 2012-11-16
Strength per Unit : 400 mg / 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-11-16
Date Granted : 2015-07-07
Patent Expiration Date : 2031-03-31
Date Granted : 2016-10-11
Brand Name : EPCLUSA
Patent Number : 2794669
Filing Date : 2011-03-31
Strength per Unit : 400 mg / 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-03-31
Date Granted : 2016-10-11
Patent Expiration Date : 2034-01-30
Date Granted : 2021-04-13
SOFOSBUVIR, VELPATASVIR
Brand Name : EPCLUSA
Patent Number : 2921160
Filing Date : 2014-01-30
Strength per Unit : 400 mg / 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2034-01-30
Date Granted : 2021-04-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
